AU7956400A - Mucosal preventives for mastitis - Google Patents

Mucosal preventives for mastitis

Info

Publication number
AU7956400A
AU7956400A AU79564/00A AU7956400A AU7956400A AU 7956400 A AU7956400 A AU 7956400A AU 79564/00 A AU79564/00 A AU 79564/00A AU 7956400 A AU7956400 A AU 7956400A AU 7956400 A AU7956400 A AU 7956400A
Authority
AU
Australia
Prior art keywords
preventives
mastitis
mucosal
mucosal preventives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79564/00A
Other languages
English (en)
Inventor
Toshikatsu Hayashi
Takuya Koji
Takuji Seo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Schering Plough Animal Health KK
Original Assignee
Takeda Schering Plough Animal Health KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Schering Plough Animal Health KK filed Critical Takeda Schering Plough Animal Health KK
Publication of AU7956400A publication Critical patent/AU7956400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU79564/00A 1999-10-29 2000-10-24 Mucosal preventives for mastitis Abandoned AU7956400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/309116 1999-10-29
JP30911699A JP2003171291A (ja) 1999-10-29 1999-10-29 乳房炎用粘膜予防剤
PCT/JP2000/007445 WO2001032205A1 (fr) 1999-10-29 2000-10-24 Preventifs muqueux contre la mastite

Publications (1)

Publication Number Publication Date
AU7956400A true AU7956400A (en) 2001-05-14

Family

ID=17989091

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79564/00A Abandoned AU7956400A (en) 1999-10-29 2000-10-24 Mucosal preventives for mastitis

Country Status (3)

Country Link
JP (1) JP2003171291A (fr)
AU (1) AU7956400A (fr)
WO (1) WO2001032205A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE526978T1 (de) * 2004-08-17 2011-10-15 Hunter Immunology Ltd Verfahren zur herstellung von oral abgetöteten vakzinen
JP5114628B2 (ja) * 2005-02-25 2013-01-09 国立大学法人三重大学 リポソームワクチンの作製法
KR20080108096A (ko) * 2006-02-07 2008-12-11 니혼 바이오로지컬즈 가부시키가이샤 신규 백신 담체
JP2009286730A (ja) * 2008-05-29 2009-12-10 Nai Kk 新規乳房炎ワクチン
CN102294026A (zh) * 2010-11-17 2011-12-28 赤峰博恩药业有限公司 奶牛链球菌乳房炎灭活疫苗及其制备方法
CN102389568B (zh) * 2011-04-25 2014-02-19 通威股份有限公司 一种预防金鲳鱼溃疡病的疫苗
WO2015093546A1 (fr) * 2013-12-18 2015-06-25 旭化成株式会社 Procédé pour détecter des bactéries du genre streptococcies dans le lait
EP3085769B1 (fr) * 2013-12-18 2020-04-15 Asahi Kasei Kabushiki Kaisha Procédé de détection de bactéries coliformes dans le lait
NZ721267A (en) 2013-12-18 2017-04-28 Asahi Chemical Ind Method for detecting staphylococcus contained in milk
CN111387133B (zh) * 2020-02-25 2021-04-16 中国农业大学 一种肺炎克雷伯杆菌噬菌体抑制小鼠乳腺炎模型建立方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1182555A (en) * 1967-10-16 1970-02-25 Saphar Lab Ltd An Anti-Mastitis Vaccine
IE51174B1 (en) * 1980-04-14 1986-10-29 Merck & Co Inc Group b streptococcal capsular polysaccharides
JPH0356426A (ja) * 1989-07-24 1991-03-12 Gifu Meneki Kenkyusho:Kk ウシ乳房炎予防および治療用抗体含有材料
ZA948590B (en) * 1993-11-05 1996-05-02 Lilly Co Eli Vaccine design and production
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant

Also Published As

Publication number Publication date
JP2003171291A (ja) 2003-06-17
WO2001032205A1 (fr) 2001-05-10

Similar Documents

Publication Publication Date Title
AU3565800A (en) Can end
AU7098000A (en) Signed group criteria
AU2002218623A1 (en) Robot system
AU2002218627A1 (en) Robot system
AU3330100A (en) Repeater
AU1914501A (en) Split repeater
AU1854901A (en) Novel method
AU2001285417A1 (en) Object catcher
AU7003500A (en) Delivery box
AUPQ253199A0 (en) Non-prostanoid prostaglandin I2-agonist
AU4439700A (en) Insulator
AU7956400A (en) Mucosal preventives for mastitis
AU2678600A (en) Matching engine
AU2001252578A1 (en) Preventives for influenza
AU5054099A (en) Non-aqueous anthelmintic composition
AU4376199A (en) Mucosal targeting immunisation
AU5552200A (en) Method
AU7303200A (en) Identification
AU2985200A (en) Novel sialoadhesins
AU1161901A (en) Spray technology improvement
AU6741800A (en) Bioactive compound
AU4585100A (en) Method
AU2194201A (en) Novel compound
AU6372199A (en) Viral mastitis
AU1164401A (en) Method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase